The recent challenges in global distribution have highlighted the importance of securing vital medications like Ivermectin. Trusting on overseas manufacturers exposes regions to potential vulnerabilities, including shipping delays, expense fluctuations, and even political risks. Moving towards domestic procurement of Ivermectin offers a multitude o